Target
Pro-glucagon
Ligand
BDBM142038
Substrate
n/a
Meas. Tech.
SPA Assay
pH
7.4±n/a
Ki
53±n/a nM
Citation
 Didiuk, MFilipski, KJGuzman-Perez, ALee, ECPfefferkorn, JAStevens, BTu, M Quinolinyl glucagon receptor modulators US Patent  US8927577 Publication Date 1/6/2015 
Target
Name:
Pro-glucagon
Synonyms:
GCG | GLUC_HUMAN | Glucagon | Glucagon receptor (GCGR)
Type:
Enzyme
Mol. Mass.:
20907.95
Organism:
Homo sapiens (Human)
Description:
P01275
Residue:
180
Sequence:
MKSIYFVAGLFVMLVQGSWQRSLQDTEEKSRSFSASQADPLSDPDQMNEDKRHSQGTFTSDYSKYLDSRRAQDFVQWLMNTKRNRNNIAKRHDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRGRRDFPEEVAIVEELGRRHADGSFSDEMNTILDNLAARDFINWLIQTKITDRK
  
Inhibitor
Name:
BDBM142038
Synonyms:
US8927577, 117 | US8927577, 19 | US8927577, 32
Type:
Small organic molecule
Emp. Form.:
C27H31N3O3
Mol. Mass.:
445.5533
SMILES:
Cc1cc2ccccc2nc1NC(C1CC(C)(C)C1)c1ccc(cc1)C(=O)NCCC(O)=O
Structure:
Search PDB for entries with ligand similarity: